ORACLE INVESTMENT MANAGEMENT INC Hedge Fund

CIK: 0001012622 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: May 15, 2019

Total Value ($000): $469,971 (100.0% shares, 0.0% debt)

Holdings (18)

— QUIDEL CORP 26.5%

Value ($000) $124,626 Shares 1,903,558 Est. Cost $25223.83 Unrealized —

— AMARIN CORP PLC 23.1%

Value ($000) $108,504 Shares 5,226,580 Est. Cost $603.60 Unrealized —

— ACCELERATE DIAGNOSTICS INC 19.5%

Value ($000) $91,428 Shares 4,349,563 Est. Cost $22.26 Unrealized —

— BIOHAVEN PHARMACTL HLDG CO L 11.2%

Value ($000) $52,571 Shares 1,021,392 Est. Cost $48.99 Unrealized —

— DERMIRA INC 3.9%

Value ($000) $18,529 Shares 1,367,436 Est. Cost $13.55 Unrealized —

— BIOLASE INC 3.1%

Value ($000) $14,692 Shares 6,173,250 Est. Cost $1.21 Unrealized —

— VERMILLION INC 2.4%

Value ($000) $11,299 Shares 9,825,289 Est. Cost $1445.80 Unrealized —

— MOTUS GI HLDGS INC 2.3%

Value ($000) $10,823 Shares 2,775,000 Est. Cost $3.11 Unrealized —

OPK OPKO HEALTH INC 2.0%

Value ($000) $9,621 Shares 3,686,194 Est. Cost $7.29 Unrealized -58.5%

PACB PACIFIC BIOSCIENCES CALIF IN 1.7%

Value ($000) $8,030 Shares 1,110,666 Est. Cost $4.84 Unrealized +49.5%

— SOLENO THERAPEUTICS INC 1.7%

Value ($000) $7,856 Shares 3,813,558 Est. Cost $1.79 Unrealized —

— AGENUS INC 0.9%

Value ($000) $4,036 Shares 1,358,918 Est. Cost $2.27 Unrealized —

— BIOHAVEN PHARMACTL HLDG CO L 0.7%

Value ($000) $3,415 Shares 739,000 Est. Cost $48.99 Unrealized —

— CONTRAFECT CORP 0.5%

Value ($000) $2,236 Shares 5,621,199 Est. Cost $2.27 Unrealized —

BIIB BIOGEN INC 0.3%

Value ($000) $1,505 Shares 6,368 Est. Cost $213.68 Unrealized +47.4%

— AMARIN CORP PLC 0.1%

Value ($000) $410 Shares 165,400 Est. Cost $603.60 Unrealized —

— ACCELERATE DIAGNOSTICS INC 0.1%

Value ($000) $377 Shares 206,400 Est. Cost $22.26 Unrealized —

PACB PACIFIC BIOSCIENCES CALIF IN 0.0%

Value ($000) $13 Shares 500,000 Est. Cost $4.84 Unrealized +49.5%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	QUIDEL CORP	1,903,558	$124,626	26.5%	$25223.83	—	COM	74838J101
—	AMARIN CORP PLC	5,226,580	$108,504	23.1%	$603.60	—	SPONS ADR NEW	023111206
—	ACCELERATE DIAGNOSTICS INC	4,349,563	$91,428	19.5%	$22.26	—	COM	00430H102
—	BIOHAVEN PHARMACTL HLDG CO L	1,021,392	$52,571	11.2%	$48.99	—	COM	G11196105
—	DERMIRA INC	1,367,436	$18,529	3.9%	$13.55	—	COM	24983L104
—	BIOLASE INC	6,173,250	$14,692	3.1%	$1.21	—	COM NEW	090911207
—	VERMILLION INC	9,825,289	$11,299	2.4%	$1445.80	—	COM NEW	92407M206
—	MOTUS GI HLDGS INC	2,775,000	$10,823	2.3%	$3.11	—	COM	62014P108
OPK	OPKO HEALTH INC	3,686,194	$9,621	2.0%	$7.29	-58.5%	COM	68375N103
PACB	PACIFIC BIOSCIENCES CALIF IN	1,110,666	$8,030	1.7%	$4.84	+49.5%	COM	69404D108
—	SOLENO THERAPEUTICS INC	3,813,558	$7,856	1.7%	$1.79	—	COM NEW	834203200
—	AGENUS INC	1,358,918	$4,036	0.9%	$2.27	—	COM NEW	00847G705
—	BIOHAVEN PHARMACTL HLDG CO L	739,000	$3,415	0.7%	$48.99	—	Call	G11196105
—	CONTRAFECT CORP	5,621,199	$2,236	0.5%	$2.27	—	COM	212326102
BIIB	BIOGEN INC	6,368	$1,505	0.3%	$213.68	+47.4%	COM	09062X103
—	AMARIN CORP PLC	165,400	$410	0.1%	$603.60	—	Call	023111206
—	ACCELERATE DIAGNOSTICS INC	206,400	$377	0.1%	$22.26	—	Call	00430H102
PACB	PACIFIC BIOSCIENCES CALIF IN	500,000	$13	0.0%	$4.84	+49.5%	Call	69404D108